Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03640247 · ClinicalTrials.gov registry record · Phase 1
Pain Medications Following Thyroidectomy and Parathyroidectomy
A Phase 1 study, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 126
- Enrollment target
NCT03640247 is a Phase 1 study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 126 participants.
The verdict
NCT03640247, a Phase 1 study, has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 126 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen on patients undergoing thyroidectomy and parathyroidectomy.
Interventions
- DRUG Non-narcotic group regimen
- DRUG Narcotic group regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2018-11-15 |
| Est. Completion | 2019-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03640247
The ClinicalTrials.gov registry entry for NCT03640247 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Non-narcotic group regimen is the first listed.
NCT03640247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03640247 about?
NCT03640247 is a clinical study titled "Pain Medications Following Thyroidectomy and Parathyroidectomy". The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen on patients undergoing thyroidectomy and parathyroidectomy.
What is the current status of trial NCT03640247?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 126 participants. The study started on 2018-11-15. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03640247?
The interventions under investigation include: Non-narcotic group regimen (DRUG), Narcotic group regimen (DRUG).
Who is sponsoring clinical trial NCT03640247?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.